Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Translate Bio Inc (TBIO)

Translate Bio Inc (TBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,633,597
  • Shares Outstanding, K 74,322
  • Annual Sales, $ 7,800 K
  • Annual Income, $ -113,290 K
  • 60-Month Beta 0.88
  • Price/Sales 10.69
  • Price/Cash Flow N/A
  • Price/Book 4.74
Trade TBIO with:

Options Overview

Details
  • Implied Volatility 125.02%
  • Historical Volatility 105.26%
  • IV Percentile 66%
  • IV Rank 18.62%
  • IV High 308.23% on 03/10/20
  • IV Low 83.11% on 11/19/20
  • Put/Call Vol Ratio 0.25
  • Today's Volume 120
  • Volume Avg (30-Day) 1,548
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 8,666
  • Open Int (30-Day) 11,698

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.30
  • Number of Estimates 6
  • High Estimate -0.23
  • Low Estimate -0.41
  • Prior Year -0.48
  • Growth Rate Est. (year over year) +37.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.40 +0.23%
on 02/23/21
34.64 -38.08%
on 02/08/21
-4.28 (-16.63%)
since 02/03/21
3-Month
18.13 +18.31%
on 12/31/20
34.64 -38.08%
on 02/08/21
-0.53 (-2.41%)
since 12/03/20
52-Week
6.80 +215.44%
on 03/09/20
34.64 -38.08%
on 02/08/21
+13.79 (+180.03%)
since 03/03/20

Most Recent Stories

More News
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat or prevent debilitating or life-threatening...

TBIO : 21.45 (-2.41%)
Translate Bio Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Progress

/p>

TBIO : 21.45 (-2.41%)
Translate Bio to Present at the SVB Leerink Virtual 10th Annual Global Healthcare Conference

Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat or prevent debilitating or life-threatening...

TBIO : 21.45 (-2.41%)
Sanofi (SNY) Q4 Earnings & Sales Miss, 2021 EPS View Bright

Sanofi's (SNY) Q4 earnings and sales miss estimates. Dupixent drives sales growth in the quarter

REGN : 446.73 (-1.79%)
SNY : 45.46 (-1.04%)
GSK : 34.24 (+0.44%)
TBIO : 21.45 (-2.41%)
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat or prevent debilitating or life-threatening...

TBIO : 21.45 (-2.41%)
Translate Bio Announces Timing of Interim Results from mRNA Therapeutic Clinical Trial in Patients with Cystic Fibrosis; Data Expected in Early Q2 2021

-- MRT5005 is the first clinical-stage mRNA therapeutic with nebulized delivery to the lung and first to be administered in multiple doses for the treatment of a chronic genetic disease --

TBIO : 21.45 (-2.41%)
6 Biotech/Drug Stocks Up Manifold in 2020 Thanks to COVID-19

We discuss six biotech/drug stocks, NVAX, VXRT, MRNA, TBIO, INO and BNTX that have more than doubled in 2020 on the back of their progress in coronavirus vaccine development.

MRNA : 131.22 (-10.62%)
NVAX : 183.61 (-10.86%)
TBIO : 21.45 (-2.41%)
INO : 9.56 (-4.59%)
BNTX : 97.25 (-7.36%)
Translate Bio Announces Departure of Chief Financial Officer

Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat or prevent debilitating or life-threatening...

TBIO : 21.45 (-2.41%)
The Zacks Analyst Blog Highlights: INO, NVAX, TBIO and VXRT

The Zacks Analyst Blog Highlights: INO, NVAX, TBIO and VXRT

NVAX : 183.61 (-10.86%)
TBIO : 21.45 (-2.41%)
INO : 9.56 (-4.59%)
VXRT : 6.36 (-10.92%)
4 Biotechs Likely to Gain on Coronavirus Vaccine Efforts

In the race to develop a coronavirus vaccine, Pfizer and its partner BioNTech have a lead, closely followed by Moderna. However, four other biotechs, NVAX, TBIO, INO and VXRT, still hold potential to gain...

NVAX : 183.61 (-10.86%)
TBIO : 21.45 (-2.41%)
INO : 9.56 (-4.59%)
VXRT : 6.36 (-10.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Translate Bio, Inc. operates as a therapeutics company. It develops transformative medicines for the treatment of diseases caused by protein and gene dysfunction. Translate Bio, Inc. is based in MA, United States.

See More

Key Turning Points

3rd Resistance Point 22.77
2nd Resistance Point 22.49
1st Resistance Point 21.97
Last Price 21.45
1st Support Level 21.17
2nd Support Level 20.89
3rd Support Level 20.37

See More

52-Week High 34.64
Fibonacci 61.8% 24.01
Last Price 21.45
Fibonacci 50% 20.72
Fibonacci 38.2% 17.43
52-Week Low 6.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar